Unicycive Therapeutics (UNCY) Shares Issued (2020 - 2026)

Unicycive Therapeutics (UNCY) has 7 years of Shares Issued data on file, last reported at $2.2 million in Q1 2026.

• Quarterly Shares Issued rose 11.54% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 11.54% YoY) and the FY2025 annual result came in at $2.0 million, up 173.51% from the prior year.
• Shares Issued improved to $2.2 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $13.7 million in Q3 2024 to a low of $725525.0 in Q2 2025.
• A 5-year average of $4.5 million and a median of $2.0 million in 2025 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2024 — Shares Issued soared 1667.51% — and 2025, when it slumped 94.46%.
• Tracing UNCY's Shares Issued over 5 years: stood at $1.3 million in 2022, then surged by 667.28% to $10.3 million in 2023, then slumped by 92.78% to $743333.0 in 2024, then jumped by 173.51% to $2.0 million in 2025, then grew by 7.95% to $2.2 million in 2026.
• The last three Shares Issued figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $816875.0 (Q3 2025), per Business Quant data.